| TTM
|
12/31/2025
|
12/31/2024
|
12/31/2023
|
12/31/2022
|
|
|---|---|---|---|---|---|
| Total Revenue
|
0 | 0 | 0 | 0 | 0 |
| Selling, General and Administrative Expenses
|
-1,923.7020 | -1,979.6010 | -1,740.1820 | -1,536.7540 | -1,695.6180 |
| Depreciation, Amortization and Depletion
|
0 | 0 | -0.7230 | -1.8100 | -2 |
| Provision Expense/Write-Back
|
31.8150 | -12.0370 | -18.1690 | 24.9970 | 9.6060 |
|
Operating Income/Expenses
|
-1,891.8870 | -1,991.6380 | -1,759.0740 | -1,513.5670 | -1,688.0120 |
|
Total Operating Profit/Loss
|
-1,891.8870 | -1,991.6380 | -1,759.0740 | -1,513.5670 | -1,688.0120 |
| Total Net Finance Income/Expense
|
120.6280 | 67.7110 | 59.1110 | 116.4150 | 68.2420 |
| Net Investment Income
|
2,400.3610 | -350.4530 | -234.2310 | 709.7360 | 631.5850 |
| Irregular Income/Expenses
|
6 | 6 | 0 | 2 | 20.6860 |
|
Other Income/Expense, Non-Operating
|
0 | -- | 0 | -22.0420 | 0.3040 |
|
Non-Operating Income/Expenses, Total
|
2,472.6580 | -276.7420 | -175.1200 | 806.1090 | 720.8170 |
|
Pretax Income
|
580.7710 | -2,268.3800 | -1,934.1940 | -707.4580 | -967.1950 |
|
Net Income from Continuing Operations
|
580.7710 | -2,268.3800 | -1,934.1940 | -707.4580 | -967.1950 |
|
Net Income after Extraordinary Items and Discontinued Operations
|
580.7710 | -2,268.3800 | -1,934.1940 | -707.4580 | -967.1950 |
|
Net Income after Non-Controlling/Minority Interests
|
580.7720 | -2,268.3800 | -1,934.1940 | -707.4580 | -967.1950 |
|
Net Income Available to Common Stockholders
|
580.7720 | -2,268.3800 | -1,934.1940 | -707.4580 | -967.1950 |
|
Dilution to Earnings
|
-2,258.9370 | -- | 0 | -723.7740 | -1,151.6090 |
|
Diluted Net Income Available to Common Stockholders
|
-1,678.1650 | -2,268.3800 | -1,934.1940 | -1,431.2320 | -2,118.8040 |
| Basic EPS
|
-0.01 | -0.01 | -0.01 | 0.00 | -0.00 |
| Diluted EPS
|
-0.01 | -0.01 | -0.01 | 0.00 | -0.01 |
|
Basic Weighted Average Shares Outstanding
|
355,569.9160 | 325,368.8630 | 279,928.4410 | 263,287.5830 | 248,005.3840 |
|
Diluted Weighted Average Shares Outstanding
|
366,399 | 325,368.8630 | 279,928.4410 | 263,287.5830 | 248,005.3840 |
| Income Statement, Supplemental
|
|||||
|
EBIT
|
453.8320 | -2,342.2690 | -1,999.2260 | -830.8230 | -1,041.8380 |
|
EBITDA
|
453.8320 | -2,342.2690 | -1,998.5030 | -829.0130 | -1,039.8380 |
|
Normalized EBITDA
|
-2,093.6070 | -2,055.8360 | -1,550.2370 | -1,536.8500 | 795.2540 |
|
Normalized Income
|
-1,584.5522 | -1,981.9470 | -1,485.9280 | -1,415.2950 | 867.8970 |
|
Total Unusual Items
|
-2,547.4390 | 286.4330 | 448.2660 | -707.8370 | 1,835.0920 |
|
Total Unusual Items Excluding Goodwill
|
-2,547.4390 | 286.4330 | 448.2660 | -707.8370 | 1,835.0920 |
|
Tax Effect of Unusual Items
|
-382.1158 | 0 | 0 | 0 | 0 |
12/31/2022 - 11/28/2001
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade